{"title":"新产品条目[双氯芬酸依他亚糖醛酸酯、磷酸埃米他司韦、[18F]氟雌二醇、甲磺酸弗莫内替尼、依卡他定、利索卡布他定、马拉亮氨酸、纳西塔单抗、帕那福司阿法、帕帕尼、吡氟福司他F18、利乐那cept(新适应症)、索特罗维单抗、盐酸维洛嗪(新适应证)","authors":"","doi":"10.1358/dot.2021.57.7.3333207","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New product intros [diclofenac etalhyaluronate, emitasvir phosphate, [18F]fluoroestradiol, furmonertinib mesilate, idecabtagene vicleucel, lisocabtagene maraleucel, naxitamab, pabinafusp alfa, pamiparib, piflufolastat F18, rilonacept (new indication), sotrovimab, viloxazine hydrochloride (new indica\",\"authors\":\"\",\"doi\":\"10.1358/dot.2021.57.7.3333207\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":85144,\"journal\":{\"name\":\"Medicamentos de actualidad. Drugs of today\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicamentos de actualidad. Drugs of today\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1358/dot.2021.57.7.3333207\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicamentos de actualidad. Drugs of today","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1358/dot.2021.57.7.3333207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
New product intros [diclofenac etalhyaluronate, emitasvir phosphate, [18F]fluoroestradiol, furmonertinib mesilate, idecabtagene vicleucel, lisocabtagene maraleucel, naxitamab, pabinafusp alfa, pamiparib, piflufolastat F18, rilonacept (new indication), sotrovimab, viloxazine hydrochloride (new indica